Abstract:Importance Morphea is a rare disease of unknown etiology without satisfactory treatment for skin sclerosis and soft tissue atrophy. Objective To provide clinical, histologic, and transcriptome evidence of the antisclerotic and regenerative effects of sequential fat grafting with fresh fat and cryopreserved stromal vascular fraction gel (SVF gel) for morphea. Design, Setting, and Participants This single-center, nonrandomized controlled trial was conducted between January 2022 and March 2023 in the Department of Plastic and Reconstructive Surgery of Nanfang Hospital, Southern Medical University and included adult participants with early-onset or late-onset morphea who presented with varying degrees of skin sclerosis and soft tissue defect. Interventions Group 1 received sequential grafting of fresh fat and cryopreserved SVF gel (at 1 and 2 months postoperation). Group 2 received single autologous fat grafting. All patients were included in a 12-month follow-up. Main Outcome and Measures The primary outcome included changes in the modified Localized Scleroderma Skin Severity Index (mLoSSI) and Localized Scleroderma Skin Damage Index (LoSDI) scores as evaluated by 2 independent blinded dermatologists. The histologic and transcriptome changes of morphea skin lesions were also evaluated. Results Of 44 patients (median [IQR] age, 26 [23-33] years; 36 women [81.8%]) enrolled, 24 (54.5%) were assigned to group 1 and 20 (45.5%) to group 2. No serious adverse events were noted. The mean (SD) mLoSSI scores at 12 months showed a 1.6 (1.50) decrease in group 1 and 0.9 (1.46) in group 2 ( P = .13), whereas the mean (SD) LoSDI scores at 12 months showed a 4.3 (1.34) decrease in group 1 and 2.1 (1.07) in group 2 ( P &lt; .001), indicating that group 1 had more significant improvement in morphea skin damage but not disease activity compared with group 2. Histologic analysis showed improved skin regeneration and reduced skin sclerosis in group 1, whereas skin biopsy specimens of group 2 patients did not show significant change. Transcriptome analysis of skin biopsy specimens from group 1 patients suggested that tumor necrosis factor α signaling via NFκB might contribute to the immunosuppressive and antifibrotic effect of sequential fat grafting. A total of 15 hub genes were captured, among which many associated with morphea pathogenesis were downregulated and validated by immunohistochemistry, such as EDN1 , PAI-1 , and CTGF . Conclusions and Relevance The results of this nonrandomized trial suggest that sequential fat grafting with fresh fat and cryopreserved SVF gel was safe and its therapeutic effect was superior to that of single autologous fat grafting with improved mLoSSI and LoSDI scores. Histological and transcriptomic changes further support the effectiveness after treatment. Trial Registration Chinese Clinical Trial Registry identifier: ChiCTR2200058003

Case Report: Exacerbation after fat grafting in patients with active localized scleroderma

Outcomes of Fat Grafting in the Active Versus Quiescent Phase of Localized Scleroderma

Nonoperative Management of a Liponecrotic Lump after Augmentation Mammaplasty with Autologous Fat Injection : a Case Report and Review of the Literature

Association Between Fat Graft Retention and Blood Flow in Localized Scleroderma Patients: A Pilot Study

Fat Grafting Reduces Skin Hyperpigmentation of Localized Scleroderma Patients: A Prospective Self-controlled Study

Tracking Fat Grafts by Magnetic Resonance Imaging: A Comparative Study of Adolescent and Adult Patients with Stable Localized Scleroderma

Total Facial Autologous Fat Grafting for Treating Skin Manifestations in Scleroderma

Autologous fat transplantation. Long-term follow-up

Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea

"Comparative study of adipose-derived stem cells from localized scleroderma patients and healthy donors in treating skin fibrosis"

Fat Grafting and Adipose Stem Cells for Facial Systemic Sclerosis: A Systematic Review of the Literature

Combination of Autologous Fat Grafting and Negative-Pressure Wound Therapy for the Treatment of Scalp Linear Scleroderma

Use of autologous fat grafting in prevention and treatment of expansion complications

Correction of Hemifacial Atrophy with Autologous Fat Transplantation

Autologous Fat Transfer Rescues Expanded Skin from Expansion Failure: A Retrospective Cohort Study in Asians

Long-term Complications after Liquid Silicone Injection: A Case Report and Literature Review

Autologous Fat Grafting to the Breast for Cosmetic Enhancement: Experience in 66 Patients with Long-Term Follow Up

Fat transplantation induces dermal adipose regeneration and reverses skin fibrosis through dedifferentiation and redifferentiation of adipocytes

Improvement of facial scar appearance and microcirculation by autologous lipofilling

Single-cell RNA sequencing identifies inherent abnormalities of adipose-derived stem cells from nonlesional sites of patients with localized scleroderma

Autologous Fat or Adipose-Derived Stem Cell Grafting in Systemic Sclerosis Treatment: a Systematic Review and Meta-Analysis.